Next Article in Journal
The Association between Nutritional Status and In-Hospital Mortality among Patients with Heart Failure—A Result of the Retrospective Nutritional Status Heart Study 2 (NSHS2)
Next Article in Special Issue
Association of Zinc Deficiency with Development of CVD Events in Patients with CKD
Previous Article in Journal
The Design and Development of a Food Composition Database for an Electronic Tool to Assess Food Intake in New Caledonian Families
Previous Article in Special Issue
Maintenance of Skeletal Muscle to Counteract Sarcopenia in Patients with Advanced Chronic Kidney Disease and Especially Those Undergoing Hemodialysis
 
 
Review
Peer-Review Record

The Importance of Phosphate Control in Chronic Kidney Disease

Nutrients 2021, 13(5), 1670; https://doi.org/10.3390/nu13051670
by Ken Tsuchiya 1,* and Taro Akihisa 2
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Nutrients 2021, 13(5), 1670; https://doi.org/10.3390/nu13051670
Submission received: 19 April 2021 / Revised: 6 May 2021 / Accepted: 12 May 2021 / Published: 14 May 2021

Round 1

Reviewer 1 Report

The manuscript entitled " The importance of phosphate control in chronic kidney disease " by Tsuchiya  and Akihisa is a well structured review on the strategies to control phosphate levels in CKD-MB to improve prognosis.

Major points:

1.       The authors should refer Klotho as αKlotho in the whole manuscript, to distinguish it from its paralog βKlotho.

2.       The Abstract should clearly state the aim of this review.

3.       Edit lines 76 to 81 as it gives the impression that FGF23 is more important in regulating the action of sodium dependent phosphate transport than PTH.

4.       Edit lines 98 to 104  as αKlotho is not always necessary an obligatory co-receptor of FGF23 action, depends on the FGFR and the tissue.

5.       Lines 172-174: the reference is from 2014. It would be a nice part of the review to discuss the adequacy of the several ways to test αKlotho in blood samples.

Minor points:

1.       Line 53: change absorption by reabsorption

2.       Line 59-61: where is the missing percentage reabsorbed?

3.       Figure 2 left panel may have copy right issues with Kidney International as it is not an adaptation but a copy of the image. Check.

4.       Line 533: change FBF23 by FGF23

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

see the attacmnent

Comments for author File: Comments.pdf

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Back to TopTop